14-Nov-2026 20:23:42

GUFICBIOGeneral news

GUFICBIO Q2 FY27 ; CONS NET PROFIT UP 39.50% AT ₹23.47 CR (YOY), UP 5.18% (QOQ)

REVENUE UP 21.61% AT ₹288.27 CR (YOY), UP 10.53% (QOQ) EBITDA UP 28.14% AT ₹48.49 CR (YOY), UP 4.05% (QOQ) MARGINS AT 16.82% VS 15.97% (YOY), 17.87% (QOQ)

Gufic Biosciences Ltd

Open attachment

← Back to feed